1. Home
  2. RZLT vs RVMDW Comparison

RZLT vs RVMDW Comparison

Compare RZLT & RVMDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • RVMDW
  • Stock Information
  • Founded
  • RZLT 2010
  • RVMDW N/A
  • Country
  • RZLT United States
  • RVMDW United States
  • Employees
  • RZLT N/A
  • RVMDW 443
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • RVMDW
  • Sector
  • RZLT Health Care
  • RVMDW
  • Exchange
  • RZLT Nasdaq
  • RVMDW Nasdaq
  • Market Cap
  • RZLT 303.1M
  • RVMDW N/A
  • IPO Year
  • RZLT N/A
  • RVMDW N/A
  • Fundamental
  • Price
  • RZLT $5.74
  • RVMDW $0.66
  • Analyst Decision
  • RZLT Strong Buy
  • RVMDW
  • Analyst Count
  • RZLT 8
  • RVMDW 0
  • Target Price
  • RZLT $11.63
  • RVMDW N/A
  • AVG Volume (30 Days)
  • RZLT 394.2K
  • RVMDW N/A
  • Earning Date
  • RZLT 11-11-2024
  • RVMDW N/A
  • Dividend Yield
  • RZLT N/A
  • RVMDW N/A
  • EPS Growth
  • RZLT N/A
  • RVMDW N/A
  • EPS
  • RZLT N/A
  • RVMDW N/A
  • Revenue
  • RZLT N/A
  • RVMDW N/A
  • Revenue This Year
  • RZLT N/A
  • RVMDW N/A
  • Revenue Next Year
  • RZLT N/A
  • RVMDW N/A
  • P/E Ratio
  • RZLT N/A
  • RVMDW N/A
  • Revenue Growth
  • RZLT N/A
  • RVMDW N/A
  • 52 Week Low
  • RZLT $0.72
  • RVMDW N/A
  • 52 Week High
  • RZLT $6.10
  • RVMDW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 61.13
  • RVMDW N/A
  • Support Level
  • RZLT $5.32
  • RVMDW N/A
  • Resistance Level
  • RZLT $5.93
  • RVMDW N/A
  • Average True Range (ATR)
  • RZLT 0.30
  • RVMDW 0.00
  • MACD
  • RZLT 0.01
  • RVMDW 0.00
  • Stochastic Oscillator
  • RZLT 68.29
  • RVMDW 0.00

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: